Glenview Capital Proposes Ninth Industry-Leading Nominee to HMA Board of Directors

   Glenview Capital Proposes Ninth Industry-Leading Nominee to HMA Board of
                                  Directors

PR Newswire

NEW YORK, July 3, 2013

NEW YORK, July 3, 2013 /PRNewswire/ --Glenview Capital Management LLC, which
owns 14.6% of the common stock of Health Management Associates, Inc. (NYSE:
HMA), today added a ninth nominee to the group of healthcare leaders prepared
to serve as a Fresh Alternative for the Board of Directors of HMA. The
announcement, which also is available at www.revitalizehma.com, was made in
the following open letter to all shareholders:

July 3, 2013

Fellow HMA Shareholders:

We are pleased to present well-known and widely respected healthcare executive
JoAnn Reed as the ninth Board nominee for your consideration as the Fresh
Alternative to Revitalize HMA, along with her abbreviated biographical
information for your review.

  oJoAnn Reed

       oExecutive healthcare experience: Chief Financial Officer and Senior
         Vice President of Finance of Medco Health Solutions, Inc. from 1992
         to March 2008, and advisor to the CEO from April 2008 to April 2009;
         senior finance positions at Medco Containment Services, Inc. from
         1988 to 1992; Assistant Controller of CBS Records, American
         Re-insurance Co, Standard and Poor's and Timeplex Inc.
       oExtensive board experience: Director of American Tower Corporation
         since 2007, member of the audit committee; Director of Waters
         Corporation since 2006; Trustee of St. Mary's College of Notre Dame,
         Indiana.
       oExtensive knowledge and experience as a senior financial executive in
         healthcare services, with broad accounting, finance and healthcare
         industry expertise.

We encourage all shareholders to review the documentation available at
www.revitalizehma.com as well as all information that may be provided by the
sitting HMA Board so that each shareholder can make a well-informed decision
in this democratic process.

Respectfully yours,

Glenview Capital Management

About Glenview Capital Management
Glenview Capital Management is a private investment management firm with more
than $6 billion of assets under management. The firm was founded in 2000 and
manages capital for qualified investors through a series of private investment
funds, and has offices in New York and London. Glenview is focused on
delivering attractive absolute returns through an intense focus on deep,
fundamental research and individual security selection.

For More Information go to www.revitalizehma.com or contact:

Scott Tagliarino/Katrina Allen
ASC Advisors LLC
(203) 992-1230

GLENVIEW CAPITAL PARTNERS, L.P., GLENVIEW CAPITAL MASTER FUND, LTD., GLENVIEW
INSTITUTIONAL PARTNERS, L.P., GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.,
GLENVIEW CAPITAL OPPORTUNITY FUND, L.P., GLENVIEW CAPITAL MANAGEMENT, LLC AND
LARRY ROBBINS (COLLECTIVELY, "GLENVIEW") INTEND TO FILE WITH THE SECURITIES
AND EXCHANGE COMMISSION (THE "SEC") A DEFINITIVE CONSENT STATEMENT AND
ACCOMPANYING CONSENT CARD TO BE USED TO SOLICIT WRITTEN CONSENTS FROM THE
STOCKHOLDERS OF HEALTH MANAGEMENT ASSOCIATES, INC. ("HMA" OR "THE COMPANY") IN
CONNECTION WITH GLENVIEW'S INTENT TO TAKE CORPORATE ACTION BY WRITTEN CONSENT.
ALL STOCKHOLDERS OF THE COMPANYARE ADVISED TO READ THE DEFINITIVE CONSENT
STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF WRITTEN CONSENTS
FROM THE STOCKHOLDERS OF THE COMPANY, BY GLENVIEW AND OTHER PARTICIPANTS IN
SUCH SOLICITATION (COLLECTIVELY, THE "PARTICIPANTS") WHEN THEY BECOME
AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. INFORMATION
RELATING TO THE PARTICIPANTS IS CONTAINED IN THE PRELIMINARY CONSENT STATEMENT
FILED ON JUNE 25, 2013 WITH THE SEC AND IS AVAILABLE AT NO CHARGE ON THE SEC'S
WEB SITE AT HTTP://WWW.SEC.GOV. WHEN COMPLETED, THE DEFINITIVE CONSENT
STATEMENT AND FORM OF WRITTEN CONSENT WILL BE FURNISHED TO SOME OR ALL OF THE
STOCKHOLDERS OF THE COMPANY AND WILL, ALONG WITH OTHER RELEVANT DOCUMENTS, BE
AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN
ADDITION, GLENVIEW WILL PROVIDE COPIES OF THE DEFINITIVE CONSENT STATEMENT AND
ACCOMPANYING CONSENT CARD (WHEN AVAILABLE) WITHOUT CHARGE UPON REQUEST TO
OKAPI PARTNERS LLC, TELEPHONE: (877) 869-0171.

Cautionary Statement Regarding Forward-Looking Statements

This presentation may include "forward-looking statements" that reflect
current views of future events. Statements that include the words "expect,"
"intend," "plan," "believe," "project," "anticipate," "will," "may," "would"
and similar statements of a future or forward-looking nature are often used to
identify forward-looking statements. Similarly, statements that describe our
objectives, plans or goals are forward-looking. Glenview's forward-looking
statements are based on its current intent, belief, expectations, estimates
and projections regarding the Company and projections regarding the industry
in which it operates. These statements are not guarantees of future
performance and involve risks, uncertainties, assumptions and other factors
that are difficult to predict and that could cause actual results to differ
materially. Accordingly, you should not rely upon forward-looking statements
as a prediction of actual results and actual results may vary materially from
what is expressed in or indicated by the forward-looking statements. Except
to the extent required by applicable law, no person undertakes any obligation
to update publicly or revise any forward-looking statement, whether as a
result of new information, future developments or otherwise.

SOURCE Glenview Capital Management LLC
 
Press spacebar to pause and continue. Press esc to stop.